FI3694526T3 - Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten - Google Patents
Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten Download PDFInfo
- Publication number
- FI3694526T3 FI3694526T3 FIEP18865483.4T FI18865483T FI3694526T3 FI 3694526 T3 FI3694526 T3 FI 3694526T3 FI 18865483 T FI18865483 T FI 18865483T FI 3694526 T3 FI3694526 T3 FI 3694526T3
- Authority
- FI
- Finland
- Prior art keywords
- cystic fibrosis
- patient
- agnostic
- genotype
- rescue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762570795P | 2017-10-11 | 2017-10-11 | |
| PCT/US2018/055435 WO2019075214A2 (en) | 2017-10-11 | 2018-10-11 | INDEPENDENT RESCUEING OF THE GENOTYPE OF CYSTIC FIBROSIS WITH BICARBONATE CHANNELS WITH SMALL MOLECULES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3694526T3 true FI3694526T3 (fi) | 2025-02-06 |
Family
ID=66100102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP18865483.4T FI3694526T3 (fi) | 2017-10-11 | 2018-10-11 | Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US12090164B2 (enExample) |
| EP (1) | EP3694526B1 (enExample) |
| JP (2) | JP7355335B2 (enExample) |
| AU (2) | AU2018348214C1 (enExample) |
| CA (1) | CA3076246A1 (enExample) |
| DK (1) | DK3694526T3 (enExample) |
| ES (1) | ES3009563T3 (enExample) |
| FI (1) | FI3694526T3 (enExample) |
| PT (1) | PT3694526T (enExample) |
| WO (1) | WO2019075214A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7355335B2 (ja) | 2017-10-11 | 2023-10-03 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ | 小分子重炭酸イオンチャネルを用いた嚢胞性線維症の遺伝子型非依存性救済 |
| KR20240164801A (ko) | 2022-03-21 | 2024-11-20 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 암포테리신 b의 지질-코팅된 결정을 포함하는 이온 채널 보형 조성물 |
| WO2025019806A2 (en) * | 2023-07-19 | 2025-01-23 | The Board Of Trustees Of The University Of Illinois | Restoring physiology with small molecule mimics of missing proteins |
| WO2025064626A1 (en) * | 2023-09-20 | 2025-03-27 | The Board Of Trustees Of The University Of Illinois | Additive effects for molecular prosthetcs and cftr modulators in cf epithelia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU598958B2 (en) * | 1987-11-12 | 1990-07-05 | Vestar, Inc. | Improved amphotericin b liposome preparation |
| AU643141B2 (en) | 1991-03-15 | 1993-11-04 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| JP5118302B2 (ja) * | 2002-10-29 | 2013-01-16 | トランセイブ, インク. | 抗感染剤の徐放 |
| TWI249408B (en) | 2003-12-10 | 2006-02-21 | Ind Tech Res Inst | New antifungal formulation and manufacturing method thereof |
| ATE476965T1 (de) * | 2004-06-11 | 2010-08-15 | Verma Jitendra Nath | Sterol-angereicherte multilamellare amphotericin- enthaltende liposomen in kochsalzlösung und herstellungsverfahren |
| WO2011050311A1 (en) | 2009-10-22 | 2011-04-28 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Use of endostatin peptides for the treatment of fibrosis |
| US8945605B2 (en) * | 2011-06-07 | 2015-02-03 | Parion Sciences, Inc. | Aerosol delivery systems, compositions and methods |
| US20180015115A1 (en) * | 2014-11-04 | 2018-01-18 | The Board Of Trustees Of The University Of Illinois | Restoring physiology with small molecule mimics of missing proteins |
| DK3439668T3 (da) * | 2016-04-08 | 2024-09-02 | Univ Illinois | Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose |
| WO2017181193A2 (en) * | 2016-04-15 | 2017-10-19 | The Uab Research Foundation | Methods and compounds for stimulating read-through of premature termination codons |
| JP7355335B2 (ja) | 2017-10-11 | 2023-10-03 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ | 小分子重炭酸イオンチャネルを用いた嚢胞性線維症の遺伝子型非依存性救済 |
-
2018
- 2018-10-11 JP JP2020517886A patent/JP7355335B2/ja active Active
- 2018-10-11 US US16/754,651 patent/US12090164B2/en active Active
- 2018-10-11 PT PT188654834T patent/PT3694526T/pt unknown
- 2018-10-11 AU AU2018348214A patent/AU2018348214C1/en active Active
- 2018-10-11 CA CA3076246A patent/CA3076246A1/en active Pending
- 2018-10-11 EP EP18865483.4A patent/EP3694526B1/en active Active
- 2018-10-11 WO PCT/US2018/055435 patent/WO2019075214A2/en not_active Ceased
- 2018-10-11 FI FIEP18865483.4T patent/FI3694526T3/fi active
- 2018-10-11 ES ES18865483T patent/ES3009563T3/es active Active
- 2018-10-11 DK DK18865483.4T patent/DK3694526T3/da active
-
2023
- 2023-07-06 JP JP2023111218A patent/JP2023126932A/ja active Pending
-
2024
- 2024-09-16 US US18/886,316 patent/US20250000886A1/en active Pending
- 2024-09-16 US US18/886,318 patent/US20250009775A1/en active Pending
- 2024-11-06 AU AU2024259758A patent/AU2024259758A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019075214A2 (en) | 2019-04-18 |
| JP2020536859A (ja) | 2020-12-17 |
| PT3694526T (pt) | 2025-01-20 |
| US20200352970A1 (en) | 2020-11-12 |
| DK3694526T3 (da) | 2025-02-03 |
| CA3076246A1 (en) | 2019-04-18 |
| EP3694526A2 (en) | 2020-08-19 |
| WO2019075214A3 (en) | 2020-04-02 |
| ES3009563T3 (en) | 2025-03-27 |
| AU2018348214B2 (en) | 2024-08-08 |
| US20250009775A1 (en) | 2025-01-09 |
| JP7355335B2 (ja) | 2023-10-03 |
| AU2024259758A1 (en) | 2024-11-21 |
| JP2023126932A (ja) | 2023-09-12 |
| AU2018348214A1 (en) | 2020-04-23 |
| US20250000886A1 (en) | 2025-01-02 |
| EP3694526B1 (en) | 2024-12-04 |
| EP3694526A4 (en) | 2021-06-09 |
| US12090164B2 (en) | 2024-09-17 |
| AU2018348214C1 (en) | 2025-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3694526T3 (fi) | Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten | |
| MY199967A (en) | Combinations of lsd1 inhibitors for use in the treatment of solid tumors | |
| PH12018500765A1 (en) | N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use | |
| PH12020500543A1 (en) | Nonracemic mixtures and uses thereof | |
| PH12021551792A1 (en) | Bi-ligand drug conjugate and use thereof | |
| PH12018500088A1 (en) | Substituted tricyclics and method of use | |
| HK1206297A1 (en) | Pharmaceutical compositions for combination therapy | |
| WO2017091767A3 (en) | Drug formulations for cancer treatment | |
| MY161078A (en) | Topical formulation for a jak inhibitor | |
| EP4599848A3 (en) | Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant | |
| MY194313A (en) | Substituted chromanes and method of use | |
| WO2015151079A3 (en) | Auristatin analogues and their conjugates with cell-binding molecules | |
| WO2020102804A3 (en) | Pharmaceutical combination for treatment of cancer | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| MX2017003102A (es) | Formulacion para inhalacion liquida que comprende rpl554. | |
| PH12020500091A1 (en) | Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7] annulene-2-carboxylic acid and its use for the treatment of cancer | |
| EP4609912A3 (en) | New use of a combination of sacubitril and valsartan | |
| PH12018502422A1 (en) | Nanoliposomal irinotecan for use in treating small cell lung cancer | |
| MX418886B (es) | Derivado de pirimidina que inhibe el crecimiento de celulas cancerosas y uso medicinal del mismo | |
| SA519401614B1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
| MX2021002042A (es) | Inhibidores de arginasa y sus metodos de uso. | |
| MX2023001445A (es) | Compuestos de piridazina 6-sustituidos como degradadores de smarca2 y/o smarca4. | |
| NZ759173A (en) | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | |
| MX2020007062A (es) | Composiciones farmacéuticas para la piel tópicas que contienen cerdulatinib y usos de estas. |